Advanced theranostic materials / edited by Ashutosh Tiwari, Hirak K. Patra and Jeong-Woo Choi

Contributor(s):

Resource type: Ressourcentyp: Buch (Online)Book (Online)Language: English Series: Advanced materials seriesPublisher: Hoboken, New Jersey : John Wiley & Sons Inc.-Scrivener, [2015]Copyright date: ©2015Description: 1 Online-Ressource (1 online resource)ISBN:

1118998898
111899891X
1118998928
1118998901
9781118998915
9781118998922
9781118998892
9781118998908
1118998294
9781118998298

Subject(s):

Additional physical formats: 9781118998298 | Erscheint auch als: Advanced theranostics materials. Druck-Ausgabe. Hoboken, New Jersey : John Wiley & Sons Inc.-Scrivener, [2015]DDC classification:

616.07/54

LOC classification:

R857.N34

DOI: DOI: 10.1002/9781118998922Online resources:

Zugang im Netz der DHBW

Summary: "The present book is covers the recent advances in the development on the regulation of such theragnosis system and their biomedical perspectives to act as a future nanomedicine. Advanced Theranostics Materials is written by a distinguished group of contributors and provides comprehensive coverage of the current literature, up-to-date overview of all aspects of advanced theranostics materials ranging from system biology, diagnostics, imaging, image-guided therapy, therapeutics, biosensors, and translational medicine and personalized medicine, as well as the much broader task of covering most topics of biomedical research. The books focusses on the following topics: Part 1: System biology and translational medicine Aberrant Signaling Pathways: Hallmark of Cancer Cells and Target for Nanotherapeutics Application of Nanoparticles in Cancer Treatment Biomacromolecule-Gated Mesoporous Silica Drug Delivery Systems Construction of Functional DNA Nanostructures for Theranostic Applications Smart Polypeptide Nanocarriers for Malignancy Therapeutics Part 2: Imaging and therapeutics Dimercaptosuccinic acid-coated magnetic nanoparticles as a localized delivery system in cancer immunotherapy Cardiovascular nanomedicine Chitosan-based systems for sustained drug release Nanocapsules in biomedicine: promises and challenges Chitosan-based polyelectrolyte complexes: characteristics and application in formulation of particulate drug carriers Part 3: Diagnostics and featured prognostics Non-invasive Glucose Biosensors based on Nanomaterials Self/directed Assembly of Nanoparticles: A review on various approaches Ion exchangers - an open window for the development of advanced materials with pharmaceutical and medical applications New Titanium Alloys for Biomedical Applications"--Summary: 5.3 Evaluation of Nanoparticle-Induced Toxicity -- 5.4 Magnetic Targeting of Nanoparticles -- 5.5 A Specific Example: DMSA-Coated Magnetic Nanoparticles -- 5.6 Conclusions -- Acknowledgments -- References -- Chapter 6: Cardiovascular Nanomedicine -- 6.1 Introduction -- 6.2 Nanoscale Cardiovascular Diagnostics -- 6.3 Nanotechnology in Cardiovascular Therapeutics -- 6.4 Nanotechnology in the Surgery of Cardiovascular Disease -- 6.5 Conclusion -- References -- Chapter 7: Chitosan-based Interpenetrating Polymeric Network Systems for Sustained Drug Release -- 7.1 Introduction -- 7.2 IPNs and Their Uses in Drug Delivery -- 7.3 Chitosan -- 7.4 Chitosan-Tamarind Seed Polysaccharide IPN Microparticles and Matrix Tablets for Sustained Release of Aceclofenac -- 7.5 Chitosan-Hydroxyethyl Cellulose IPN Microspheres of Isoniazid -- 7.6 Chitosan-Methyl Cellulose IPN Microspheres of Theophylline -- 7.7 Chitosan-Acrylamide-Grafted-Poly(Vinyl Alcohol) and Hydrolyzed Acrylamide-Grafted-Poly(Vinyl Alcohol) IPN Microgels of Cefadroxil -- 7.8 Chitosan-Poly(N-Isopropylacrylamide) IPN Discs of Diclofenac Sodium -- 7.9 Chitosan-Poly(Ethylene Oxide-Grafted-Acrylamide) Semi-IPN Hydrogel Microspheres of Capecitabine -- 7.10 Acrylamide-Grafted Dextran-Chitosan Semi-IPN Microspheres of Acyclovir -- 7.11 Chitosan-Acrylamide-Grafted Hydroxyethylcellulose Semi-IPN Microspheres of Diclofenac Sodium -- 7.12 Poly [N-Acryloylglycine-Chitosan] IPN Hydrogel of 5-Fluorouracil -- 7.13 Chitosan-N, N2 Dimethylacrylamide Semi-IPN Microspheres of Chlorothiazide -- 7.14 Conclusion -- References -- Chapter 8: Nanocapsules in Biomedicine -- 8.1 Nanocapsules: A Novel Nano-Drug Delivery System -- 8.2 Magic Bullets: Nanocapsules in Future Medicine -- 8.3 In Vitro Applications of Nanocapsules -- 8.4 In Vivo Applications of Nanocapsules -- 8.5 Conclusions -- References.Summary: Chapter 9: Chitosan-based Polyelectrolyte Complexes -- 9.1 Introduction -- 9.2 Chitosans: Chemical Structure, Physicochemical Properties, and Toxicological and Regulatory Aspects -- 9.3 Polyelectrolyte Complexes: Theoretical Background, Structure, and Basic Properties -- 9.4 Chitosan-based Polyelectrolyte Complexes in Particulate Drug Carriers -- 9.5 Characterization of Chitosan-Based PECs and Chitosan-based PEC Particulate Drug Carriers -- 9.6 Conclusion -- Acknowledgment -- References -- Part 3: Diagnostics and Featured Prognostics -- Chapter 10: Non-invasive Glucose Biosensors Based on Nanomaterials -- 10.1 Diabetes and Its Prevalence -- 10.2 Importance of Glucose Monitoring -- 10.3 Glucose Measurement Methods -- 10.4 Non-invasive Glucose Determination -- 10.5 Glucose Biosensors -- 10.6 New Generation of Non-invasive Glucose Biosensors-Based Nanomaterials -- 10.7 Future Perspective in Glucose Monitoring -- 10.8 Conclusion -- References -- Chapter 11: Self-Directed Assembly of Nanoparticles -- 11.1 Introduction -- 11.2 Self-Assembly through Molecular Interactions/Forces -- 11.3 Hydrogen-Bonding Interactions -- 11.4 Directed Self-Assembly by External Forces -- 11.5 Conclusion -- Acknowledgment -- References -- Index.Summary: Half Title page -- Title page -- Copyright page -- Preface -- Part 1: System Biology and Translational Medicine -- Chapter 1: Aberrant Signaling Pathways -- 1.1 Cancer -- 1.2 Pathways Deregulated in Cancer: Introduction -- 1.3 Introduction to Nanotechnology -- 1.4 Current Uses in Cancer Diagnostic -- Acknowledgment -- References -- Chapter 2: Application of Nanoparticles in Cancer Treatment -- 2.1 Introduction -- 2.2 Nanoparticles in Cancer Treatment -- 2.3 Nanoparticle Platforms as Drug Delivery Systems for Cancer Therapy -- 2.4 Theranostic Nanomedicine -- 2.5 Selective Drug Delivery and Encapsulation for Chemotherapy -- 2.6 Stimuli-Sensitive Nanopreparations -- 2.7 Multifunctional Nanopreparations -- 2.8 Cancer Nanotechnology: Future and Challenges -- References -- Chapter 3: Biomacromolecule-Gated Mesoporous Silica Drug Delivery Systems for Stimuli-Responsive Controlled Release -- 3.1 Introduction -- 3.2 Protein-Gated MSN Drug Delivery Systems -- 3.3 DNA-Gated MSN Drug Delivery Systems -- 3.4 Conclusions and Perspectives -- Acknowledgments -- References -- Chapter 4: Construction of Functional DNA Nanostructures for Theranostic Applications -- 4.1 The Progress of Structural DNA Nanotechnology -- 4.2 DNA Nanostructures for Diagnostics -- 4.3 DNA Nanostructures for Diagnostics on the Interface -- 4.4 Diagnostic in Homogeneous Solution -- 4.5 DNA Nanostructures for Therapeutics -- 4.6 Integration of Diagnosis and Therapy: Smart DNA Theranostic Nanodevices -- 4.7 Targeted Delivery -- 4.8 Controlled/Triggered Release -- 4.9 Summary and Perspectives -- References -- Part 2: Imaging and Therapeutics -- Chapter 5: Dimercaptosuccinic Acid-Coated Magnetic Nanoparticles as a Localized Delivery System in Cancer Immunotherapy -- 5.1 Introduction -- 5.2 Nanoparticle Detection and Quantification: In Vitro and In Vivo Techniques.PPN: PPN: 1679564684Package identifier: Produktsigel: ZDB-35-UBC | ZDB-35-WIC

Holdings ( 0 )

No physical items for this record